Dachaigh › Tumor neuroendocrine gastro-enteropancreatic › Ohio

Sgrùdaidhean clionaigeach Tumor neuroendocrine gastro-enteropancreatic ann an Ohio

Tha 3 sgrùdaidhean airson Tumor neuroendocrine gastro-enteropancreatic a’ lorg phàirtichean aig làraichean ann an Ohio.

Teacsa sgrùdaidh oifigeil (Beurla)

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

Cincinnati Children's Hospital Medical Center, Cincinnati

A’ fastadhÌre 1

24 Months – 18 Years · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06441331

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

Research Facility, Columbus

A’ fastadhÌre 1

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07165132

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

UH Cleveland Medical Center, Cleveland
Ohio State University, Columbus

A’ fastadhÌre 1/2

Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT05636618

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.